Beijing Leadman Biochemistry Co (SZSE:300289) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Change In Receivables?

Beijing Leadman Biochemistry Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Beijing Leadman Biochemistry Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Beijing Leadman Biochemistry Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥44.0 Mil. It means Beijing Leadman Biochemistry Co's Accounts Receivable declined by ¥44.0 Mil from Dec. 2022 to Dec. 2023 .

Beijing Leadman Biochemistry Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥129.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beijing Leadman Biochemistry Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 124.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beijing Leadman Biochemistry Co's liquidation value for the three months ended in Mar. 2024 was ¥884.1 Mil.

Beijing Leadman Biochemistry Co Change In Receivables Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Change In Receivables Chart

Beijing Leadman Biochemistry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

60.41

0.64

2.85

6.25

43.98

Beijing Leadman Biochemistry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Leadman Biochemistry Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Beijing Leadman Biochemistry Co (SZSE:300289) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beijing Leadman Biochemistry Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	129.037	/	94.624	*	91
=	124.44

2. In Ben Graham's calculation of liquidation value, Beijing Leadman Biochemistry Co's accounts receivable are only considered to be worth 75% of book value:

Beijing Leadman Biochemistry Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	847.733	-	102.922	+	0.75 * 129.037	+	0.5 * 85.077
=	884.1

Beijing Leadman Biochemistry Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5 Hongda South Road, Beijing, CHN

Website

http://www.leadmanbio.com

Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.

Executives

Ding Yao Liang	Executives
Wang Xiao Hong	Supervisors
Zhang Hai Tao	Executives
Zhang Ya Li	Supervisors
Sun Qian	Director
Wang Jian Hua	Directors, executives
Wang Yi Xing	Directors, executives
Yang Lu Ping	Securities Affairs Representative
Niu Ju Hui	Secretary Dong
Zhang Kun	Director
Shen Guang Qian	Directors, executives
Ma Yan Wen	Director
Wang Lan Zhen	Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines